Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1988 Nov 1;168(5):1659–1673. doi: 10.1084/jem.168.5.1659

Clonal analysis of functionally distinct human CD4+ T cell subsets

PMCID: PMC2189105  PMID: 2903211

Abstract

A large number of CD4+ T cell clones, obtained from peripheral blood T lymphocytes by direct limiting dilution, allowed us to address the question whether functional heterogeneity exists within the human CD4+ T cell subset. Cytotoxic capacity of cloned T cells was analyzed with the use of anti-CD3 antibodies and target cells bearing FcR for murine IgG. 6 of 12 CD4+ clones obtained were able to lyse Daudi or P815 cells in the presence of anti-CD3 antibodies. The remaining six CD4+ T cell clones tested did not display anti-CD3-mediated cytotoxic activity and did not acquire this cytotoxic capacity during a culture period of 20 wk. In the absence of anti-CD3 mAb, no lytic activity against Daudi, P815, and K562 target cells was observed under normal culture conditions. Phenotypic analysis of these two distinct types of CD4+ T cells did not reveal differences with regard to reactivity with CDw29 (4B4) and CD45R (2H4) mAbs that have been described to recognize antigens associated with helper suppressor/inducer (respectively) CD4+ cells. The CD4+ clones without anti-CD3-mediated cytotoxic activities (Th2) consistently showed a high expression level of CD28 antigens, whereas the cytotoxic clones (Th1) expressed low amounts of CD28. Th1 CD4+ clones did produce IL-2, IFN-gamma, and TNF-alpha/beta, whereas the Th2 T cell clones produced minimal amounts of IL-2 and only low levels of INF-gamma and TNF-alpha/beta in response to anti-CD3 mAbs and PMA. Although not all CD4+ clones did release IL-4, there was no correlation with cytotoxic activity. Moreover, as compared with the Th1 CD4+ clones, Th2 CD4+ T cell clones proliferated moderately in response to immobilized anti-CD3 mAbs. However, proliferation reached the level of the cytotoxic clones when anti-CD28 mABs were present during culture. Both CD4+ subsets provided help for B cell differentiation upon stimulation with anti-CD3 mAbs. Our data suggest that the human CD4+ subset, in analogy to the murine system, comprises two functionally distinct T cell subpopulations, both of which are able to exert helper activity for polyclonal B cell differentiation, but which differ in cytotoxic capacity, lymphokine production, and requirements for proliferation. A function for these two types of T cells in the immune response is discussed.

Full Text

The Full Text of this article is available as a PDF (900.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bank I., Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J Exp Med. 1985 Oct 1;162(4):1294–1303. doi: 10.1084/jem.162.4.1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brooks C. G., Holscher M. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes. J Immunol. 1987 Mar 1;138(5):1331–1337. [PubMed] [Google Scholar]
  3. Brooks C. G., Urdal D. L., Henney C. S. Lymphokine-driven "differentiation" of cytotoxic T-cell clones into cells with NK-like specificity: correlations with display of membrane macromolecules. Immunol Rev. 1983;72:43–72. doi: 10.1111/j.1600-065x.1983.tb01072.x. [DOI] [PubMed] [Google Scholar]
  4. Chen L. K., Bensussan A., Burns G. F., Tourvieille B., Soulié A., Sasportes M. Allospecific proliferative human T-cell clones acquire the cytotoxic effector function after three months in culture, in IL-2 conditioned medium. Hum Immunol. 1986 Sep;17(1):30–36. doi: 10.1016/0198-8859(86)90071-6. [DOI] [PubMed] [Google Scholar]
  5. Chen L. K., Mathieu-Mahul D., Sasportes M., Degos L., Bensussan A. What is a T-cell clone? Effect of rIFN on T-cell clone function and T-cell receptor gene rearrangement. Hum Immunol. 1986 Nov;17(3):214–223. doi: 10.1016/0198-8859(86)90273-9. [DOI] [PubMed] [Google Scholar]
  6. Christmas S. E., Meager A., Moore M. Production of interferon and tumour necrosis factor by cloned human natural cytotoxic lymphocytes and T cells. Clin Exp Immunol. 1987 Aug;69(2):441–450. [PMC free article] [PubMed] [Google Scholar]
  7. Coffman R. L., Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol. 1986 Feb 1;136(3):949–954. [PubMed] [Google Scholar]
  8. De Rie M. A., Kabel P., Sauerwein R. W., Van Lier R. A., Von dem Borne A. E., Melief C. J., Miedema F. Anti-HLA-class II monoclonal antibodies inhibit polyclonal B cell differentiation in vitro at the accessory cell level. Eur J Immunol. 1987 Jun;17(6):881–886. doi: 10.1002/eji.1830170623. [DOI] [PubMed] [Google Scholar]
  9. Fleischer B. Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture. Nature. 1984 Mar 22;308(5957):365–367. doi: 10.1038/308365a0. [DOI] [PubMed] [Google Scholar]
  10. Fleischer B., Wagner H. Significance of T4 or T8 phenotype of human cytotoxic T-lymphocyte clones. Curr Top Microbiol Immunol. 1986;126:101–109. doi: 10.1007/978-3-642-71152-7_13. [DOI] [PubMed] [Google Scholar]
  11. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  12. Green L. M., Reade J. L., Ware C. F., Devlin P. E., Liang C. M., Devlin J. J. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin. J Immunol. 1986 Dec 1;137(11):3488–3493. [PubMed] [Google Scholar]
  13. Hara T., Fu S. M., Hansen J. A. Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J Exp Med. 1985 Jun 1;161(6):1513–1524. doi: 10.1084/jem.161.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jacobson S., Richert J. R., Biddison W. E., Satinsky A., Hartzman R. J., McFarland H. F. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol. 1984 Aug;133(2):754–757. [PubMed] [Google Scholar]
  15. Jung G., Honsik C. J., Reisfeld R. A., Müller-Eberhard H. J. Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4479–4483. doi: 10.1073/pnas.83.12.4479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kansas G. S., Wood G. S., Fishwild D. M., Engleman E. G. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8. J Immunol. 1985 May;134(5):2995–3002. [PubMed] [Google Scholar]
  17. Kim J., Woods A., Becker-Dunn E., Bottomly K. Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med. 1985 Jul 1;162(1):188–201. doi: 10.1084/jem.162.1.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Klein J. R., Pasternack M. S., Bevan M. J. Activation requirements for antigen- and mitogen-induced interferon-gamma release from cytotoxic T lymphocytes. J Immunol. 1985 Apr;134(4):2456–2461. [PubMed] [Google Scholar]
  19. Kuritani T., Cooper M. D. Human B cell differentiation. II. Pokeweed mitogen-responsive B cells belong to a surface immunoglobulin D-negative subpopulation. J Exp Med. 1982 May 1;155(5):1561–1566. doi: 10.1084/jem.155.5.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kurt-Jones E. A., Hamberg S., Ohara J., Paul W. E., Abbas A. K. Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med. 1987 Dec 1;166(6):1774–1787. doi: 10.1084/jem.166.6.1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lamb J. R., Zanders E. D., Feldmann M., Lake P., Eckels D. D., Woody J. N., Beverley P. C. The dissociation of interleukin-2 production and antigen-specific helper activity by clonal analysis. Immunology. 1983 Nov;50(3):397–405. [PMC free article] [PubMed] [Google Scholar]
  22. Leist T., Titmas R., Parti S., Meager A. Antibodies to synthetic polypeptides corresponding to hydrophilic regions of human interferon gamma. Mol Immunol. 1985 Aug;22(8):929–936. doi: 10.1016/0161-5890(85)90079-3. [DOI] [PubMed] [Google Scholar]
  23. Lindsley M. D., Torpey D. J., 3rd, Rinaldo C. R., Jr HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells. J Immunol. 1986 Apr 15;136(8):3045–3051. [PubMed] [Google Scholar]
  24. Meager A., Parti S., Leung H., Woolley J., Peil E., Sidhu S., Roberts T. A two-site sandwich immunoradiometric assay of human lymphotoxin with monoclonal antibodies and its applications. J Immunol Methods. 1987 Nov 23;104(1-2):31–42. doi: 10.1016/0022-1759(87)90484-4. [DOI] [PubMed] [Google Scholar]
  25. Mentzer S. J., Barbosa J. A., Burakoff S. J. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition. J Immunol. 1985 Jul;135(1):34–38. [PubMed] [Google Scholar]
  26. Meuer S. C., Schlossman S. F., Reinherz E. L. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4395–4399. doi: 10.1073/pnas.79.14.4395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Miedema F., van Oostveen J. W., Terpstra F. G., van den Wall Bake A. W., Willemze R., Rauws E. A., Bieger R., van 't Veer M. B., Catovsky D., Melief C. J. Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cells. J Clin Invest. 1985 Dec;76(6):2139–2143. doi: 10.1172/JCI112219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mingari M. C., Moretta A., Maggi E., Pantaleo G., Gerosa F., Romagnani S., Moretta L. Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones. Eur J Immunol. 1984 Nov;14(11):1066–1069. doi: 10.1002/eji.1830141121. [DOI] [PubMed] [Google Scholar]
  29. Moretta A., Pantaleo G., Lopez-Botet M., Moretta L. Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex. J Exp Med. 1985 Sep 1;162(3):823–838. doi: 10.1084/jem.162.3.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Moretta A., Pantaleo G., Moretta L., Mingari M. C., Cerottini J. C. Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J Exp Med. 1983 Aug 1;158(2):571–585. doi: 10.1084/jem.158.2.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moretta L., Mingari M. C., Sekaly P. R., Moretta A., Chapuis B., Cerottini J. C. Surface markers of cloned human T cells with various cytolytic activities. J Exp Med. 1981 Aug 1;154(2):569–574. doi: 10.1084/jem.154.2.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Morimoto C., Letvin N. L., Boyd A. W., Hagan M., Brown H. M., Kornacki M. M., Schlossman S. F. The isolation and characterization of the human helper inducer T cell subset. J Immunol. 1985 Jun;134(6):3762–3769. [PubMed] [Google Scholar]
  33. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  34. Paliard X., de Waal Malefijt R., Yssel H., Blanchard D., Chrétien I., Abrams J., de Vries J., Spits H. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol. 1988 Aug 1;141(3):849–855. [PubMed] [Google Scholar]
  35. Raulet D. H., Bevan M. J. A differentiation factor required for the expression of cytotoxic T-cell function. Nature. 1982 Apr 22;296(5859):754–757. doi: 10.1038/296754a0. [DOI] [PubMed] [Google Scholar]
  36. Rotteveel F. T., Braakman E., Robbe B., Lucas C. J. Recognition of influenza virus-infected B-cell lines by human influenza virus-specific CTL. Cell Immunol. 1988 Feb;111(2):473–481. doi: 10.1016/0008-8749(88)90110-4. [DOI] [PubMed] [Google Scholar]
  37. Rudd C. E., Morimoto C., Wong L. L., Schlossman S. F. The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens. J Exp Med. 1987 Dec 1;166(6):1758–1773. doi: 10.1084/jem.166.6.1758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rümke H. C., Miedema F., ten Berge I. J., Terpstra F., van der Reijden H. J., van de Griend R. J., de Bruin H. G., von dem Borne A. E., Smit J. W., Zeijlemaker W. P. Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia. J Immunol. 1982 Jul;129(1):419–426. [PubMed] [Google Scholar]
  39. Saizawa K., Rojo J., Janeway C. A., Jr Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor. Nature. 1987 Jul 16;328(6127):260–263. doi: 10.1038/328260a0. [DOI] [PubMed] [Google Scholar]
  40. Sauerwein R. W., Van der Meer W. G., Van Oostveen J. W., Miedema F., Aarden L. A. Anti-CD3 antibodies induce T helper function for human B cell differentiation in vitro by an interleukin 2-independent pathway. Eur J Immunol. 1988 Jan;18(1):133–137. doi: 10.1002/eji.1830180120. [DOI] [PubMed] [Google Scholar]
  41. Schrezenmeier H., Kurrle R., Wagner H., Fleischer B. Activation of human T lymphocytes. III. Triggering of bystander cytotoxicity in cytotoxic T cell clones by antibodies against the T3 antigen or by a calcium ionophore. Eur J Immunol. 1985 Oct;15(10):1019–1024. doi: 10.1002/eji.1830151011. [DOI] [PubMed] [Google Scholar]
  42. Shaw S., Goldstein G., Springer T. A., Biddison W. E. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction. J Immunol. 1985 May;134(5):3019–3026. [PubMed] [Google Scholar]
  43. Spits H., Yssel H., Leeuwenberg J., De Vries J. E. Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur J Immunol. 1985 Jan;15(1):88–91. doi: 10.1002/eji.1830150117. [DOI] [PubMed] [Google Scholar]
  44. Stohl W., Posnett D. N., Chiorazzi N. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J Immunol. 1987 Mar 15;138(6):1667–1673. [PubMed] [Google Scholar]
  45. Takai Y., Herrmann S. H., Greenstein J. L., Spitalny G. L., Burakoff S. J. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes. J Immunol. 1986 Dec 1;137(11):3494–3500. [PubMed] [Google Scholar]
  46. Tite J. P., Powell M. B., Ruddle N. H. Protein-antigen specific Ia-restricted cytolytic T cells: analysis of frequency, target cell susceptibility, and mechanism of cytolysis. J Immunol. 1985 Jul;135(1):25–33. [PubMed] [Google Scholar]
  47. Van Lier R. A., Boot J. H., De Groot E. R., Aarden L. A. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems. Eur J Immunol. 1987 Nov;17(11):1599–1604. doi: 10.1002/eji.1830171112. [DOI] [PubMed] [Google Scholar]
  48. Van Lier R. A., Brouwer M., Aarden L. A. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur J Immunol. 1988 Jan;18(1):167–172. doi: 10.1002/eji.1830180125. [DOI] [PubMed] [Google Scholar]
  49. Van Lier R. A., Pool M. O., Kabel P., Mous S., Terpstra F., De Rie M. A., Melief C. J., Miedema F. Anti-CD27 monoclonal antibodies identify two functionally distinct subpopulations within the CD4+ T cell subset. Eur J Immunol. 1988 May;18(5):811–816. doi: 10.1002/eji.1830180523. [DOI] [PubMed] [Google Scholar]
  50. Weber W. E., Buurman W. A., Vandermeeren M. M., Raus J. C. Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells. J Immunol. 1985 Oct;135(4):2337–2342. [PubMed] [Google Scholar]
  51. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol. 1984 Jul;133(1):422–427. [PubMed] [Google Scholar]
  52. van Lier R. A., Borst J., Vroom T. M., Klein H., Van Mourik P., Zeijlemaker W. P., Melief C. J. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 1987 Sep 1;139(5):1589–1596. [PubMed] [Google Scholar]
  53. van Seventer G. A., Kuijpers K. C., van Lier R. A., de Groot E. R., Aarden L. A., Melief C. J. Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies. J Immunol. 1987 Oct 15;139(8):2545–2550. [PubMed] [Google Scholar]
  54. van de Griend R. J., Bolhuis R. L., Stoter G., Roozemond R. C. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR. J Immunol. 1987 May 15;138(10):3137–3144. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES